Pisa syndrome associated with mirtazapine: a case report-Reference-Cited by-同舟云学术

Pisa syndrome associated with mirtazapine: a case report

Published:2018-12 Issue:1 Volume:19 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Yamada Yuji,Takano Harumasa^ORCID,Yamada Maki,Satake Naoko,Hirabayashi Naotsugu,Okazaki Mitsutoshi,Nakagome Kazuyuki

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/s40360-018-0272-8.pdf

Reference14 articles.

1. de Boer T. The pharmacologic profile of mirtazapine. J Clin Psychiatry. 1996;57(Suppl 4):19–25.

2. Pharmaceuticals and Medical Device Agency. Common Technical Document of mirtazapine (2.7.4). 2009; http://www.pmda.go.jp/drugs/2009/P200900035/index.html . Accessed 24 May 2018.

3. Mendez Guerrero A, Llamas S, Murcia FJ, Ruiz J. Acute Pisa syndrome after administration of a single dose of mirtazapine. Clin Neuropharmacol. 2013;36:133–4. https://doi.org/10.1097/WNF.0b013e318297593d .

4. Lu R, Hurley AD, Gourley M. Dystonia induced by mirtazapine. J Clin Psychiatry. 2002;63:452–3.

5. Ekbom K, Lindholm H, Ljungberg L. New dystonic syndrome associated with butyrophenone therapy. Z Neurol. 1972;202:94–103.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pisa Syndrome Secondary to Drugs: A Scope Review;Geriatrics;2024-07-30

2. Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report;BMC Neurology;2020-05-13

3. Mirtazapine-associated movement disorders: A literature review;Tzu Chi Medical Journal;2020

4. Mirtazapine;Reactions Weekly;2019-01